ELLIE GONYEAU: Open Payments
NPI 1114541976 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 16 payments from 6 companies in 2025. Trend: 2023 $1,689 · 2024 $698 · 2025 $1,662
Food & beverage: $1,152Consulting: $500Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $531 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $500 |
| Janssen Biotech, Inc. | 3 | $386 |
| Ardelyx, Inc. | 1 | $134 |
| Madrigal Pharmaceuticals | 2 | $100 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: XIFAXAN, TREMFYA, IBSRELA, CREON, REZDIFFRA, RINVOQ.
Industry payments across MA — which companies pay providers there.
